Vaccine composition for transdermal or mucosal administration

Abstract

The invention relates to a vaccine composition for transdermal or mucosal administration, and provides a vaccine composition including a cellular immunity promoter that is used commonly with respect to various antigens in cellular immunity induction by transdermal or transmucosal administration of an antigen, having high convenience, and providing high cellular immunity inducing effect in transdermal or transmucosal administration. The vaccine composition for transdermal or transmucosal administration for inducing cellular immunity, comprising (i) an antigen; and (ii) a pharmacologically acceptable acid or a pharmacologically acceptable salt thereof as a first cellular immunity induction promoter.

Description

technical field [0001] The present invention relates to vaccine compositions for transdermal or transmucosal administration. Background technique [0002] Vaccines that are widely used generally administer pathogens such as microorganisms or viruses or parts thereof in order to induce immunity. In addition, there are cancer vaccines, the purpose of which is to enable the cellular immune system to recognize cancer cell-specific antigens, thereby inducing a specific attack on cancer cells through the immune system, which is used as one of the means of cancer treatment. [0003] Usually, the invasion of microorganisms, viruses, due to their size, is prevented by the skin, therefore, vaccines need to be administered invasively into the body. Thus, immunization usually uses injections. However, injections have the following problems: pain, fear, injection scars and scars developed from injection scars, only medical workers can perform injections, intradermal injections with hig...

AI Technical Summary

Problems solved by technology

However, injections have the following problems: pain, fear, injection scars and scars developed from injection scars, only medical workers can perform injections, intradermal injections with high immune effects are difficult to administer, and there are needles for medical workers. It cannot be said to be the best route of administration because of the risk of infection accidents, the need to go to the hospital frequently when repeated administration is a burden on the patient's life, and the generation of medical waste that requires special disposal such as injection needles.

As an adjuvant studied in immunization by means other than injection, for example, by transdermal administration or transmucosal administration, aluminum salts such as aluminum hydroxide, aluminum phosphate, and aluminum chloride are listed; cholera toxin, Escherichia coli Toxins such as heat-resistant enterotoxin, etc., but not yet in use

Images